Most GVHD patients should have insurance, which would be how they paid for an expensive bone marrow transplant.
Developing GVHD greatly increases the cost of post transplant care, and insurance companies should be willing to pay a lot for a cure which can greatly reduce these post transplant costs.
https://www.astctjournal.org/article/S2666-6367(23)01362-3/fulltext
- Forums
- ASX - By Stock
- banter and General Discussion
MSB
mesoblast limited
Add to My Watchlist
6.65%
!
$1.77

Most GVHD patients should have insurance, which would be how...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.77 |
Change
0.110(6.65%) |
Mkt cap ! $2.255B |
Open | High | Low | Value | Volume |
$1.66 | $1.80 | $1.65 | $6.578M | 3.827M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 32981 | $1.76 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.77 | 4573 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 31282 | 1.760 |
9 | 73804 | 1.755 |
7 | 43845 | 1.750 |
10 | 24323 | 1.745 |
11 | 41034 | 1.740 |
Price($) | Vol. | No. |
---|---|---|
1.765 | 5451 | 7 |
1.770 | 20645 | 14 |
1.775 | 30423 | 4 |
1.780 | 46850 | 8 |
1.785 | 19603 | 4 |
Last trade - 11.47am 01/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online